ethyl 2-(tetrahydro-2H-pyran-2-ylamino)thiazole-5-carboxylate | 1029088-17-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: ethyl 2-(tetrahydro-2H-pyran-2-ylamino)thiazole-5-carboxylate
• 英文别名: ethyl 2-(tetrahydro-2H-pyran-2-ylamino)-1,3-thiazole-5-carboxylate；ethyl 2-(oxan-2-ylamino)-1,3-thiazole-5-carboxylate
• CAS: 1029088-17-2
• 化学式: C₁₁H₁₆N₂O₃S
• 分子量: 256.326
• InChiKey: LIIHRJYTSPPSSX-UHFFFAOYSA-N

物化性质

• 熔点：
  129-131°
• 沸点：
  393.4±52.0 °C(Predicted)
• 密度：
  1.284±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  17
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  88.7
• 氢给体数：
  1
• 氢受体数：
  6

安全信息

• 危险等级：
  IRRITANT

反应信息

• 作为反应物：
  描述：

  ethyl 2-(tetrahydro-2H-pyran-2-ylamino)thiazole-5-carboxylate 、 碘甲烷 在 sodium hydride 作用下， 以 四氢呋喃 为溶剂， 反应 3.0h， 以40%的产率得到ethyl 2-(methyl(tetrahydro-2H-pyran-2-yl)amino)thiazole-5-carboxylate
  参考文献：
  名称：

  WO2008/61795

  摘要：

  公开号：
• 作为产物：
  描述：

  3,4-二氢-2H-吡喃 、 2-氨基噻唑-5-羧酸乙酯 在 三氟乙酸 乙酸乙酯 作用下， 以 乙腈 为溶剂， 反应 32.0h， 以yielding ethyl 2-(tetrahydro-2H-pyran-2-ylamino)thiazole-5-carboxylate (4.73 g, 64%)的产率得到ethyl 2-(tetrahydro-2H-pyran-2-ylamino)thiazole-5-carboxylate
  参考文献：
  名称：

  N-(METHYL) -1H-PYRAZOL-3-AMINE, N-(METHYL)-PYRIDIN-2-AMINE AND N-(METHYL)-THIAZOL-2-AMINE DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS, LIKE E.G. ALZHEIMER'S

  摘要：

  本发明涉及式（II）的新化合物，可用于治疗与淀粉样蛋白相关的一组紊乱和异常，如阿尔茨海默病，以及与淀粉样蛋白类似的蛋白质相关的疾病或病况。本发明的化合物还可用于治疗与视觉系统组织的病理性异常/变化相关的眼部疾病。本发明还涉及包含这些化合物的制药组合物，并且涉及使用这些化合物制备用于治疗或预防与淀粉样和/或淀粉样类似蛋白质相关的疾病或病况的药物。还公开了一种治疗或预防与淀粉样和/或淀粉样类似蛋白质相关的疾病或病况的方法。

  公开号：

  US20100183513A1

文献信息

• N-(METHYL) -1H-PYRAZOL-3-AMINE, N-(METHYL)-PYRIDIN-2-AMINE AND N-(METHYL)-THIAZOL-2-AMINE DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS, LIKE E.G. ALZHEIMER'S
  申请人：Froestl Wolfgang

  公开号：US20100183513A1

  公开（公告）日：2010-07-22

  The present invention relates to novel compounds of formula (II) that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating, or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed.

  本发明涉及式（II）的新化合物，可用于治疗与淀粉样蛋白相关的一组紊乱和异常，如阿尔茨海默病，以及与淀粉样蛋白类似的蛋白质相关的疾病或病况。本发明的化合物还可用于治疗与视觉系统组织的病理性异常/变化相关的眼部疾病。本发明还涉及包含这些化合物的制药组合物，并且涉及使用这些化合物制备用于治疗或预防与淀粉样和/或淀粉样类似蛋白质相关的疾病或病况的药物。还公开了一种治疗或预防与淀粉样和/或淀粉样类似蛋白质相关的疾病或病况的方法。
• NOVEL COMPOUND FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS
  申请人：FROESTL Wolfgang

  公开号：US20120309791A1

  公开（公告）日：2012-12-06

  The present invention relates to novel compounds of formula (II) that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating, or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed

  本发明涉及公式（II）的新化合物，可用于治疗与淀粉样蛋白相关的一组疾病和异常，例如阿尔茨海默病，以及与淀粉样蛋白类似蛋白质相关的疾病或病况。本发明的化合物还可用于治疗与视觉系统组织病理异常/变化相关的眼部疾病。本发明还涉及包含这些化合物的制药组合物以及使用这些化合物制备治疗或预防与淀粉样和/或淀粉样类似蛋白质相关的疾病或病况的药物的用途。还公开了一种治疗或预防与淀粉样和/或淀粉样类似蛋白质相关的疾病或病况的方法。
• N-(methyl)-pyridin-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins
  申请人：AC Immune S.A.

  公开号：EP2108644A1

  公开（公告）日：2009-10-14

  The present invention relates to novel compounds that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed.

  本发明涉及可用于治疗与淀粉样蛋白相关的一组疾病和异常（如阿尔茨海默病）以及与淀粉样蛋白相关的疾病或病症的新型化合物。本发明的化合物还可用于治疗与视觉系统组织的病理异常/变化有关的眼部疾病。本发明进一步涉及包含这些化合物的药物组合物，以及这些化合物用于制备治疗或预防与淀粉样蛋白和/或淀粉样蛋白相关的疾病或病症的药物。还公开了一种治疗或预防与淀粉样蛋白和/或淀粉样蛋白相关的疾病或病症的方法。
• N-(METHYL)-1H-PYRAZOL-3-AMINE, N-(METHYL)-PYRIDIN-2-AMINE AND N-(METHYL)-THIAZOL-2-AMINE DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS, LIKE E.G. ALZHEIMER'S
  申请人：AC Immune S.A.

  公开号：EP2102165A2

  公开（公告）日：2009-09-23
• N-(Methyl)-pyridin-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins
  申请人：AC Immune S.A.

  公开号：EP2108644B1

  公开（公告）日：2016-07-20